I was just going to state that, again, the important fact is that the committee on health is already studying the opioid epidemic and toxic drug crisis. That is what their study is called, “opioid epidemic and toxic drug crisis”. It's a serious issue.
They've looked at it. They've had 41 witnesses already studying this issue. They've had 10 meetings. I imagine that many more will be scheduled. They've heard from nurses, doctors and frontline staff. They've heard from organizations, hospitals and associations. They've heard from police associations and you name it. They're doing some tremendous work there. They're already far advanced in terms of studying the opioid epidemic and toxic drug crisis.
Again, I again want to emphasize that I truly believe that this study and this motion should have been brought up at the health committee. They've already studied contracts in the past. Medicago comes to mind. They absolutely have all the resources and all the expertise they require in order to study contracts.
It has been my position from the beginning that this should be brought in front of HESA. I don't quite understand why it would be brought here. I don't think my colleagues have adequately answered that question, but again, I'm open to the discussions we're having here today. Ultimately, our goal is to make sure that the work gets done and that this issue, this significant and serious issue that's impacting our communities, is addressed and receives the attention it rightfully deserves.
With that, I'll yield the floor to Mr. Jowhari.